{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:58:50Z","timestamp":1791219530980,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["2023NSCQ-MSX0140"],"award-info":[{"award-number":["2023NSCQ-MSX0140"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22573012"],"award-info":[{"award-number":["22573012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tips.2025.10.002","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:29:34Z","timestamp":1761658174000},"page":"1052-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Discovering next-generation dopamine transporter drugs with lower abuse potential"],"prefix":"10.1016","volume":"46","author":[{"given":"Ding","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3285-0574","authenticated-orcid":false,"given":"Weiwei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2025.10.002_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2025.10.002_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-031-21054-9_4","article-title":"Discovery and development of monoamine transporter ligands","volume":"30","author":"Aggarwal","year":"2023","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.tips.2025.10.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.5c01541","article-title":"CNSGT: generative transformer for de novo drug design targeting the central nervous system","author":"Chen","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.tips.2025.10.002_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.111.191056","article-title":"Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates","volume":"346","author":"Schmitt","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2025.10.002_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coph.2020.07.007","article-title":"Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder","volume":"56","author":"Tanda","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tips.2025.10.002_bb0030","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41586-024-07796-0","article-title":"Dopamine reuptake and inhibitory mechanisms in human dopamine transporter","volume":"632","author":"Li","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.10.002_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2025.101368","article-title":"Repurposing drugs for the human dopamine transporter through WHALES descriptors-based virtual screening and bioactivity evaluation","volume":"15","author":"Luo","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.tips.2025.10.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.124.002356","article-title":"Contrasting the reinforcing effects of the novel dopamine transport inhibitors JJC8-088 and JJC8-091 in monkeys: potential translation to medication assisted treatment","volume":"392","author":"Allen","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2025.10.002_bb0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41386-024-01826-1","article-title":"Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors","volume":"49","author":"Ecevitoglu","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2025.10.002_bb0050","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1038\/s41467-025-59511-w","article-title":"Revealing the location and dynamics of a concealed binding site in the dopamine transporter","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.10.002_bb0055","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/biomedicines9060634","article-title":"Functional characterization of the dopaminergic psychostimulant sydnocarb as an allosteric modulator of the human dopamine transporter","volume":"9","author":"Aggarwal","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.tips.2025.10.002_bb0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-024-07804-3","article-title":"Structure of the human dopamine transporter in complex with cocaine","volume":"632","author":"Nielsen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.10.002_bb0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-024-07739-9","article-title":"Structure of the human dopamine transporter and mechanisms of inhibition","volume":"632","author":"Srivastava","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.10.002_bb0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tips.2020.04.006","article-title":"Allosteric modulation of neurotransmitter transporters as a therapeutic strategy","volume":"41","author":"Niello","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2025.10.002_bb0075","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1021\/acs.jcim.3c00477","article-title":"Structure-based discovery of a novel allosteric inhibitor against human dopamine transporter","volume":"63","author":"Deng","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.tips.2025.10.002_bb0080","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s42256-024-00843-5","article-title":"Machine learning-aided generative molecular design","volume":"6","author":"Du","year":"2024","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.tips.2025.10.002_bb0085","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-3565(24)37956-X","article-title":"Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine","volume":"288","author":"Katz","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2025.10.002_bb0090","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acs.jcim.2c00462","article-title":"An in silico explainable multiparameter optimization approach for de novo drug design against proteins from the central nervous system","volume":"62","author":"Bung","year":"2022","journal-title":"J. Chem. Inf. Model."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725002263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725002263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:57:10Z","timestamp":1773269830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614725002263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0165614725002263"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2025.10.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovering next-generation dopamine transporter drugs with lower abuse potential","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2025.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}